title: Experience with a potent LH-RH agonist, buserelin, alone and in combination with testosterone for antispermatogenic activity, reversibility and toxicity in langur monkey.
abstract: Chronic intermittent treatment of LH-RH superagonist Buserelin alone or in combination with testosterone enanthate were given to adult male langurs for 90 days to evaluate antispermatogenic activity of alone and combination therapy, maintenance of normal androgenicity, possible toxic effects of agonist treatment, related side effects of testosterone supplementation and complete reversibility of the procedure. A gradual decrease in sperm count was recorded in both treatment groups, along with reduced motility and vitality of the spermatozoa. In the combination group, oligospermia was achieved in 4 out of 5 animals, whereas, only 2 animals became oligospermic in the agonist alone group. Significant decrease in serum testosterone levels along with impaired libido and other testosterone withdrawal symptoms were observed in the Buserelin alone group, conversely normal testosterone levels and libido were observed in the combination group. An elevation in haematological variables and serum total protein concomitant with a slight gain in body weight of the animals were recorded in the combination group; these changes were not encountered in the agonist alone group. Reversibility of all the altered parameters to control range was observed in both treatment groups following 75 to 90 days of treatment withdrawal.
authors.affiliation: Department of Zoology, University of Rajasthan, India.
authors.forename: N K
authors.initials: NK
authors.lastname: Lohiya
authors.forename: K
authors.initials: K
authors.lastname: Sharma
authors.forename: D
authors.initials: D
authors.lastname: Jayaprakash
authors.forename: A S
authors.initials: AS
authors.lastname: Ansari
authors.forename: M
authors.initials: M
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Sharma
mesh_terms: D000135:Acid Phosphatase / Q000097:blood; D000818:Animals; D000988:Antispermatogenic Agents; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D002064:Buserelin / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D004338:Drug Combinations; D004357:Drug Synergism; D005632:Fructose / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D000882:Haplorhini / Q000502:physiology*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007989:Libido / Q000187:drug effects / Q000502:physiology; D008274:Magnesium / Q000097:blood; D008297:Male; D009845:Oligospermia / Q000139:chemically induced; D013076:Sperm Count / Q000187:drug effects; D013081:Sperm Motility / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects*; D013737:Testis / Q000187:drug effects / Q000502:physiology; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity
chemical_list: D000988:Antispermatogenic Agents; D004338:Drug Combinations; D005632:Fructose; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007770:L-Lactate Dehydrogenase; D000135:Acid Phosphatase; D008274:Magnesium; D002064:Buserelin